We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $92M
1-Year Est. Return 25.18%
This Fund
S&P 500
This Quarter Est. Return
+0.78%
1 Year Est. Return
+25.18%
3 Year Est. Return
+50.89%
5 Year Est. Return
+36.12%
10 Year Est. Return
AUM
$86.9M
AUM Growth
-$128M
Cap. Flow
-$130M
Cap. Flow %
-148.99%
Top 10 Hldgs %
82.88%
Holding
66
New
2
Increased
24
Reduced
15
Closed
21
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
26
Medtronic
MDT
$121B
$270K 0.31%
3,001
-76
-2% -$6.8K
UWM icon
27
ProShares Ultra Russell2000
UWM
$247M
$264K 0.3%
7,887
TMO icon
28
Thermo Fisher Scientific
TMO
$227B
$262K 0.3%
524
+111
+27% +$60.1K
PM icon
29
Philip Morris
PM
$287B
$222K 0.26%
+1,401
New +$198K
IEI icon
30
iShares 3-7 Year Treasury Bond ETF
IEI
$17.6B
$219K 0.25%
1,851
-21,876
-92% -$2.55M
PFE icon
31
Pfizer
PFE
$163B
$219K 0.25%
8,651
-6,252
-42% -$164K
LEGN icon
32
Legend Biotech
LEGN
$4.25B
$219K 0.25%
+6,429
New +$231K
DJP icon
33
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$872M
$216K 0.25%
6,120
-217,812
-97% -$7.47M
IEF icon
34
iShares 7-10 Year Treasury Bond ETF
IEF
$42.2B
$209K 0.24%
2,196
-16,892
-88% -$1.58M
INCY icon
35
Incyte
INCY
$25.9B
$204K 0.23%
3,370
-1,477
-30% -$103K
BKLN icon
36
Invesco Senior Loan ETF
BKLN
$6.73B
$203K 0.23%
9,786
-294,960
-97% -$6.19M
ZURA icon
37
Zura Bio
ZURA
$584M
$140K 0.16%
108,308
+54,574
+102% +$86.1K
MREO
38
Mereo BioPharma
MREO
$41.5M
$107K 0.12%
47,630
+12,877
+37% +$36.4K
GERN icon
39
Geron
GERN
$970M
$100K 0.12%
62,973
+43,950
+231% +$107K
COGT icon
40
Cogent Biosciences
COGT
$6.03B
$83.5K 0.1%
14,015
+255
+2% +$2K
IMTX icon
41
Immatics
IMTX
$1.42B
$71.8K 0.08%
15,971
+60
+0.4% +$313
ITOS
42
DELISTED
iTeos Therapeutics
ITOS
$66.4K 0.08%
11,061
CTMX icon
43
CytomX Therapeutics
CTMX
$789M
$63.1K 0.07%
100,070
+35,811
+56% +$27.8K
ANNX icon
44
Annexon
ANNX
$923M
$55.3K 0.06%
28,591
+12,158
+74% +$40.5K
NKTX icon
45
Nkarta
NKTX
$201M
$54.1K 0.06%
29,191
-855
-3% -$1.75K
ABT icon
46
Abbott
ABT
$190B
-2,683
Closed -$304K
AOK icon
47
iShares Core Conservative Allocation ETF
AOK
$795M
-347,277
Closed -$13M
BNDX icon
48
Vanguard Total International Bond ETF
BNDX
$82.3B
-318,115
Closed -$15.6M
BSCU icon
49
Invesco BulletShares 2030 Corporate Bond ETF
BSCU
$2.71B
-10,596
Closed -$173K
EDV icon
50
Vanguard World Funds Extended Duration ETF
EDV
$3.51B
-109,780
Closed -$7.43M

Similar funds

Forefront Analytics's Q1 2025 Portfolio in Review

As of Q1 2025, Forefront Analytics held 66 positions worth $86.9M, down 60% from $215M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Forefront Analytics withdrew a net $130M in Q1 2025, closing 21 positions and reducing 15 holdings. Its most notable exit was Vanguard Total International Bond ETF, an estimated $15.6M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 97% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Forefront Analytics opened a new position in Legend Biotech worth $219K.

  • Forefront Analytics's largest Q1 2025 buy was Legend Biotech: 6,429 shares worth $219K.
  • Forefront Analytics added most to State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF in Q1 2025, an estimated $3.84M increase.
  • Forefront Analytics's biggest Q1 2025 reduction was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund, cutting an estimated $8.95M.
  • Forefront Analytics fully exited Vanguard Total International Bond ETF in Q1 2025, selling an estimated $15.6M.
  • Forefront Analytics's ten largest holdings make up 83% of its $86.9M portfolio in Q1 2025.
  • Forefront Analytics opened 2 new positions and closed 21 in Q1 2025.
  • Forefront Analytics's portfolio value fell 60% quarter-over-quarter to $86.9M.

Based on Forefront Analytics's 13F filing for Q1 2025, filed 13 May 2025.